J. Ford
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 20
- Chronic Myeloid Leukemia Treatments 11
- Iron Metabolism and Disorders 6
- Blood groups and transfusion 2
- Genetics 14
- Hemoglobinopathies and Related Disorders 14
- Co-authors
- Renaud Capdeville (6 shared papers)Charles L. Sawyers (6 shared papers)Moshe Talpaz (5 shared papers)Debra J. Resta (5 shared papers)Hagop M. Kantarjian (3 shared papers)Bin Peng (3 shared papers)Elisabeth Buchdunger (2 shared papers)Sayuri Ohno-Jones (2 shared papers)
- Journals
- Blood (10 papers)British Journal of Cancer (3 papers)The Breast (3 papers)Journal of Clinical Oncology (3 papers)New England Journal of Medicine (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
J. Ford
52 papers receiving 8.6k citations
J. Ford's Hit Papers
Peers
Comparison fields: 5 of 119
- Hematology 3.8k
- Genetics 688
- Oncology 1.3k
- Gastroenterology 326
- Cancer Research 512
Countries citing papers authored by J. Ford
This map shows the geographic impact of J. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ford more than expected).
Fields of papers citing papers by J. Ford
This network shows the impact of papers produced by J. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ford. The network helps show where J. Ford may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Ford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Hit paper breakdown → | 2001 | 4249 |
| 2 | Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome Hit paper breakdown → | 2001 | 2276 |
| 3 | 2004 | 401 | |
| 4 | 2003 | 336 | |
| 5 | Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. | 2006 | 241 |
| 6 | 1996 | 229 | |
| 7 | 2007 | 205 | |
| 8 | 2003 | 152 | |
| 9 | 1999 | 123 | |
| 10 | 2003 | 96 | |
| 11 | 1998 | 87 | |
| 12 | 1992 | 62 | |
| 13 | 2001 | 62 | |
| 14 | 1992 | 60 | |
| 15 | 1999 | 57 | |
| 16 | 1982 | 45 | |
| 17 | 2002 | 42 | |
| 18 | 1981 | 38 | |
| 19 | 1998 | 35 | |
| 20 | 2008 | 35 |
About J. Ford
J. Ford is a scholar working on Hematology, Genetics, Oncology, Biochemistry and Pathology and Forensic Medicine, having authored 53 papers that have together received 9.1k indexed citations. Recurring topics across this work include Bone health and treatments (16 papers), Hemoglobinopathies and Related Disorders (14 papers), Chronic Myeloid Leukemia Treatments (11 papers), Iron Metabolism and Disorders (6 papers), Blood transfusion and management (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Blood groups and transfusion (2 papers) and Neutropenia and Cancer Infections (2 papers). The work is most often cited by research in Hematology (3.8k citations), Genetics (688 citations), Oncology (1.3k citations), Gastroenterology (326 citations) and Cancer Research (512 citations). J. Ford has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Renaud Capdeville, Charles L. Sawyers, Moshe Talpaz, Debra J. Resta, Hagop M. Kantarjian, Bin Peng, Elisabeth Buchdunger, Sayuri Ohno-Jones, Nicholas Lydon and Stephen G. O’Brien. Their work appears in journals such as Blood, British Journal of Cancer, The Breast, Journal of Clinical Oncology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.